This is a quality controlled, peer-reviewed, open access INTERNATIONAL journal. Archives of Medicine publish research reports, and articles of various research processes like study protocols, pilot studies and pre-protocols. G6pd chloroquine Dermatomyositis rash and plaquenil recent findings Chloroquine method Hydroxychloroquine Plaquenil is a drug that is classified as an anti-malarial drug. Plaquenil is prescribed for the treatment or prevention of malaria. It is also prescribed for the treatment of rheumatoid arthritis, lupus, and the side effects of lupus such as hair loss, joint pain, and more. Plaquenil and Psoriasis - from FDA reports Summary Psoriasis is found among people who take Plaquenil, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months, also take medication Humira, and have Psoriatic arthropathy. This study is created by eHealthMe based on reports of 48,911 people who have side. Psoriasis skin disease or Stomach or bowel problems–Use with caution. May make these conditions worse. Glucose-6-phosphate dehydrogenase G6PD deficiency—May cause hemolytic anemia in patients with this condition. Kidney disease or Liver disease—Use with caution. Subject areas include studies in fields of immunology, anesthesia, cardiovascular medicine, complementary medicine, dentistry and oral medicine, pathology, pharmacology and therapeutics, dermatology, respiratory medicine, rheumatology, drugs and medicines, ear, nose and throat/otolaryngology, emergency medicine, infectious diseases, neurology, nutrition and metabolism, obstetrics and gynaecology, endocrinology, gastroenterology, genetics, geriatric medicine, haematology, oncology, ophthalmology, paediatrics, psychiatry, radiology, renal medicine, pharmacognosy, sexual health, urology, epidemiology, ethnic studies, health policy, occupational health, medical education, legal and forensic medicine, environmental medicine and public health, medicine development and safety testing, drug legislation and safety. The journal is novel, attractive, open minded, and a peer-reviewed medical periodical designed to serve as a platform for both veteran and ammeter researchers with their path breaking works as long as they are technically correct and scientifically motivated. Hydroxychloroquine for psoriasis Hydroxychloroquine Oral Uses, Side Effects, Interactions., Will you have Psoriasis with Plaquenil - eHealthMe Icd 10 plaquenil ophthalmologyWhat is the eye screening test before you take plaquenil Exacerbation of Psoriasis due to Hydroxychloroquine Sara S McCoy1*, Vivek Nagaraja2, Scott Paviol3, Johann E Gudjonsson4 and J Michelle Kahlenberg1 1 Department of Internal Medicine, Di-vision of Rheumatology, University of Michigan, USA 2 Department of Internal Medicine, Division of Rheumatology, University of Toledo, USA Exacerbation of Psoriasis due to Hydroxychloroquine. Hydroxychloroquine Oral Route Before Using - Mayo Clinic. Side Effects of Plaquenil Hydroxychloroquine, Warnings, Uses. Before using hydroxychloroquine, tell your doctor if you are allergic to any drugs, or if you have psoriasis, porphyria, liver disease, alcoholism, or glucose-6-phosphate dehydrogenase G-6-PD deficiency. Call a poison control center at once and then seek emergency medical attention if you think you have used too much of this medicine. Hydroxychloroquine may worsen psoriasis. SLIDESHOW Rheumatoid Arthritis RA Symptoms & Treatment See Slideshow. What is the dosage for hydroxychloroquine Plaquenil? The usual adult dose for treating malaria is 800 mg initially, followed by 400 mg 6-8 hours later and then 400 mg at 24 hours and 48 hours. It is known that antimalarial drugs that are helpful in LE are contraindicated in psoriasis 1. This old concept is supported by the recent study of Wolf et al. 11, who demonstrated that hydroxychloroquine induces hyperproliferation and irregular keratinization in cultured skin of psoriatic patients.